2nd Quarter - Termination — ASCENSION HEALTH for ASCENSION HEALTH (2019)

Firm

ASCENSION HEALTH

Client

ASCENSION HEALTH

Income

—

Expenses

$310,000

Expense method

A: Lobbying Disclosure Act definitions

Terminated

Jun 30, 2019

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

MISSION Act Implementation

Lobbyist	Covered position, as disclosed
NICOLE COMMODORE	—
MARK L. HAYES	—
PETER M LEIBOLD	—
DANIELLE WHITE	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Executive Office of the President (EOP)

Medicare/Medicaid MMM

Site Neutral payment policies, Medicare for All, Medicare Buy In, Affordable prescription drugs, Medicaid DSH, Medicare bad debt, wage index

Lobbyist	Covered position, as disclosed
NICOLE COMMODORE	—
MARK L. HAYES	—
PETER M LEIBOLD	—
DANIELLE WHITE New	—

Contacted: Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Affordable prescription drugs, 340B Program, HR985 FAST Generics Act of 2019, Site Neutral payment policies, S. 1895 - Lower Health Care Costs Act, S. 340 - CREATES Act, H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs Act, S. 1391 - Fair Accountability and Innovative Research Drug Pricing Act of 2019, S. 1531 - Stop the Outrageous Practice of Surprise Medical Bills Act of 2019

Lobbyist	Covered position, as disclosed
NICOLE COMMODORE	—
MARK L. HAYES	—
PETER M LEIBOLD	—
DANIELLE WHITE	—

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA)

Bills named: S. 1895 (116th), S. 340 (116th), S. 1531 (116th), H.R. 987 (116th), S. 1391 (116th), H.R. 985 (116th)

Pharmacy PHA

Affordable prescription drugs, 340B program, drug shortages

Lobbyist	Covered position, as disclosed
NICOLE COMMODORE	—
MARK L. HAYES	—
PETER M LEIBOLD	—
DANIELLE WHITE	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.